The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Develco Pharma Schweiz competitive analysis

Loading summary...

Latest oppositions filed by Develco Pharma Schweiz

Explore patent oppositions filed by Develco Pharma Schweiz against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3578173
Dosage Form Containing Oxycodone And NaloxoneEURO CELTIQUEOct 26, 2022
EP3024461
A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial TranslocationEURO CELTIQUEMay 14, 2020
EP2962686
Dosage Form Containing Oxycodone And NaloxoneEURO CELTIQUEApr 11, 2019
EP2425821
Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUEMay 11, 2017
EP2425824
Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUEMay 11, 2017

Latest PTAB cases involving Develco Pharma Schweiz

Discover the latest PTAB cases involving Develco Pharma Schweiz, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Develco Pharma Schweiz with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DEVELCO PHARMA SCHWEIZ5 - - -
EURO CELTIQUE - 44 - -
MUNDIPHARMA - 25 - -
NAPP PHARMACEUTICAL - 25 - -